Latest BIIB Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Andrew S. Fein | HC Wainwright | Maintains | Strong Buy | $228.00 → $237.00 +9.00 (4.0%) | |
| PerPlexity Drug Manufacturers - General | TipRanks - PerPlexity | Reiterates | Buy | $226.00 → $205.00 -21.00 (-9.3%) | |
| Sumant Kulkarni | Canaccord Genuity | Maintains | Strong Buy | $230.00 → $245.00 +15.00 (6.5%) | |
| Jay Olson | Oppenheimer | Maintains | Buy | $250.00 → $275.00 +25.00 (10.0%) | |
| Thomas Shrader | BTIG | Maintains | Hold | - | |
| Geoff Meacham | Citi | Maintains | Hold | $215.00 | |
| Myles Minter | William Blair | Reiterates | Buy | - | |
| Phil Nadeau | TD Cowen | Reiterates | Buy | $215.00 | |
| Jason Zemansky | BofA Securities | Maintains | Hold | $207.00 | |
| Evan Seigerman | BMO Capital | Maintains | Hold | $196.00 | |
| Ami Fadia | Needham | Maintains | Hold | - | |
| Michael Yee | UBS | Maintains | Hold | $185.00 | |
| Terence Flynn | Morgan Stanley | Maintains | Hold | $190.00 | |
| Salveen Richter | Goldman Sachs | Initiates Coverage | Buy | $225.00 → $231.00 +6.00 (2.7%) | |
| Rajesh Kumar | HSBC | Maintains | Sell | $143.00 → $150.00 +7.00 (4.9%) | |
| Andrew Tsai | Jefferies | Maintains | Buy | $210.00 | |
| Brian Abrahams | RBC Capital | Maintains | Buy | $233.00 | |
| Ilya Zubkov | Freedom Broker | Maintains | Hold | $160.00 → $185.00 +25.00 (15.6%) | |
| Emily Field | Barclays | Initiates | Hold | $185.00 | |
| David Amsellem | Piper Sandler | Reiterates | Hold | $177.00 | |
| Salim Syed | Mizuho | Maintains | Buy | $207.00 → $236.00 +29.00 (14.0%) | |
| Paul Matteis | Stifel Nicolaus | Maintains | Buy | $202.00 → $214.00 +12.00 (5.9%) | |
| Laura Chico | Wedbush | Maintains | Hold | $178.00 → $187.00 +9.00 (5.1%) | |
| Sumant Kulkarni | Canaccord Genuity | Maintains | Strong Buy | $220.00 → $230.00 +10.00 (4.5%) | |
| Laura Chico | Wedbush | Maintains | Hold | $178.00 → $187.00 +9.00 (5.1%) | |
| Yatin Suneja | Guggenheim | Maintains | Strong Buy | $185.00 → $246.00 +61.00 (33.0%) | |
| Andrew S. Fein | HC Wainwright | Maintains | Strong Buy | $194.00 → $228.00 +34.00 (17.5%) | |
| David Amsellem | Piper Sandler | Maintains | Hold | $157.00 → $177.00 +20.00 (12.7%) | |
| Srikripa Devarakonda | Truist | Maintains | Hold | $190.00 → $193.00 +3.00 (1.6%) | |
| Phil Nadeau | TD Cowen | Maintains | Strong Buy | $175.00 → $215.00 +40.00 (22.9%) | |
| Salveen Richter | Goldman Sachs | Maintains | Buy | $225.00 → $231.00 +6.00 (2.7%) | |
| Evan Seigerman | BMO Capital | Maintains | Hold | $165.00 → $196.00 +31.00 (18.8%) | |
| Geoff Meacham | Citi | Maintains | Hold | $185.00 → $215.00 +30.00 (16.2%) | |
| Mohit Bansal | Wells Fargo | Maintains | Hold | $190.00 → $200.00 +10.00 (5.3%) | |
| Brian Abrahams | RBC Capital | Maintains | Buy | $217.00 → $233.00 +16.00 (7.4%) | |
| Yatin Suneja | Guggenheim | Reiterates | Buy | $185.00 → $246.00 +61.00 (33.0%) | |
| Google Drug Manufacturers - General | TipRanks - Google | Upgrades | Hold | $204.00 → $219.00 +15.00 (7.3%) | |
| PerPlexity Drug Manufacturers - General | TipRanks - PerPlexity | Reiterates | Buy | $195.00 → $226.00 +31.00 (15.9%) | |
| Anthropic Drug Manufacturers - General | TipRanks - Anthropic | Upgrades | Hold | $198.00 → $206.00 +8.00 (4.0%) | |
| DeepSeek Drug Manufacturers - General | TipRanks - DeepSeek | Upgrades | Hold | $195.00 → $215.00 +20.00 (10.3%) | |
| xAi Drug Manufacturers - General | TipRanks - xAI | Reiterates | Buy | $199.00 → $223.00 +24.00 (12.1%) | |
| OpenAI Drug Manufacturers - General | TipRanks - OpenAI | Upgrades | Hold | $168.00 → $215.00 +47.00 (28.0%) | |
| Sumant Kulkarni | Canaccord Genuity | Reiterates | Buy | $220.00 → $230.00 +10.00 (4.5%) | |
| Myles Minter | William Blair | Maintains | Buy | - | |
| William Pickering | Bernstein | Maintains | Hold | $197.00 → $201.00 +4.00 (2.0%) | |
| Jason Zemansky | BofA Securities | Reiterates | Hold | $187.00 → $207.00 +20.00 (10.7%) | |
| Michael Yee | UBS | Maintains | Hold | $185.00 | |
| Ami Fadia | Needham | Maintains | Hold | - | |
| Brian Abrahams | RBC Capital | Maintains | Buy | $217.00 → $233.00 +16.00 (7.4%) | |
| Andrew Tsai | Jefferies | Maintains | Buy | $210.00 | |
| Jay Olson | Oppenheimer | Maintains | Buy | $205.00 → $225.00 +20.00 (9.8%) | |
| Chris Schott | JP Morgan | Maintains | Hold | $185.00 → $175.00 -10.00 (-5.4%) | |
| Geoff Meacham | Citi | Maintains | Hold | $180.00 → $185.00 +5.00 (2.8%) | |
| Thomas Shrader | BTIG | Maintains | Hold | - | |
| Evan Seigerman | BMO Capital | Maintains | Hold | $165.00 | |
| Jasper Hellweg | Argus Research | Maintains | Hold | - | |
| Salveen Richter | Goldman Sachs | Maintains | Buy | $197.00 → $225.00 +28.00 (14.2%) | |
| Srikripa Devarakonda | Truist | Maintains | Hold | $142.00 → $190.00 +48.00 (33.8%) | |
| Salim Syed | Mizuho | Maintains | Buy | $177.00 → $207.00 +30.00 (16.9%) | |
| Michael Yee | UBS | Initiates | Hold | $130.00 → $185.00 +55.00 (42.3%) | |
| Geoff Meacham | Citi | Maintains | Hold | $153.00 → $180.00 +27.00 (17.6%) | |
| Geoff Meacham | Citi | Maintains | Hold | $153.00 → $180.00 +27.00 (17.6%) |
